Merz Pharma Group North America Announces Internal Promotions within its North American Leadership Team
9/30/2013 10:29:17 AM

Merz North America (U.S. affiliate of Merz Pharma Group) today announced the internal promotions of several individuals on its North American Leadership Team.

Bhushan Hardas, MD, MBA has been appointed to the position of Chief Scientific Officer (CSO) for Merz in North America, effective immediately. Dr. Hardas joined Merz in 2004 as Vice President, Medical and Regulatory Affairs, and has served as Vice President and US Head of Research and Development and Head of Global Research and Development – Dermatology since 2011.